Results
eNauka >
Rezultati >
Impact of switching from BRAF/MEK inhibition to immune checkpoint inhibition before secondary resistance in metastatic melanoma: A EUMelaReg real-world study
| Naziv: | Impact of switching from BRAF/MEK inhibition to immune checkpoint inhibition before secondary resistance in metastatic melanoma: A EUMelaReg real-world study | Autori  : | Weichenthal, M; ...; Kandolf-Sekulovic, L; ...; (broj, koautora 20) | Godina: | 2025 | Publikacija: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Pretraži identifikator |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 36 str. S963-S964 | DOI: | 10.1016/j.annonc.2025.08.2251 | WoS-ID: | 001634626200023 | URI: | https://enauka.gov.rs/handle/123456789/1019103 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.